Literature DB >> 34152926

Barrier maintenance by S1P during inflammation and sepsis.

Anke C Ziegler1,2, Markus H Gräler1,2,3.   

Abstract

Sphingosine 1-phosphate (S1P) is a multifaceted lipid signaling molecule that activates five specific G protein-coupled S1P receptors. Despite the fact that S1P is known as one of the strongest barrier-enhancing molecules for two decades, no medical application is available yet. The reason for this lack of translation into clinical practice may be the complex regulatory network of S1P signaling, metabolism and transportation.In this review, we will provide an overview about the physiology and the network of S1P signaling with the focus on endothelial barrier maintenance in inflammation. We briefly describe the physiological role of S1P and the underlying S1P signaling in barrier maintenance, outline differences of S1P signaling and metabolism in inflammatory diseases, discuss potential targets and compounds for medical intervention, and summarize our current knowledge regarding the role of S1P in the maintenance of specialized barriers like the blood-brain barrier and the placenta.

Entities:  

Keywords:  Endothelial cell; S1P lyase; S1P receptor; apolipoprotein M; sphingosine 1-phosphate; sphingosine kinase

Mesh:

Substances:

Year:  2021        PMID: 34152926      PMCID: PMC8794530          DOI: 10.1080/21688370.2021.1940069

Source DB:  PubMed          Journal:  Tissue Barriers        ISSN: 2168-8362


  138 in total

Review 1.  Molecular mechanisms of blood vessel growth.

Authors:  E M Conway; D Collen; P Carmeliet
Journal:  Cardiovasc Res       Date:  2001-02-16       Impact factor: 10.787

2.  Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

Authors:  Barry S Shea; Sarah F Brooks; Benjamin A Fontaine; Jerold Chun; Andrew D Luster; Andrew M Tager
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

3.  Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis.

Authors:  Sven Flemming; Natalie Burkard; Michael Meir; Martin Alexander Schick; Christoph-Thomas Germer; Nicolas Schlegel
Journal:  Shock       Date:  2018-01       Impact factor: 3.454

Review 4.  New insights into functions of the sphingosine-1-phosphate transporter SPNS2.

Authors:  Sarah Spiegel; Melissa A Maczis; Michael Maceyka; Sheldon Milstien
Journal:  J Lipid Res       Date:  2019-01-17       Impact factor: 5.922

5.  Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.

Authors:  Nathalie Burg; Steven Swendeman; Stefan Worgall; Timothy Hla; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2018-11       Impact factor: 10.995

6.  Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.

Authors:  Patrick A Singleton; Steven M Dudek; Eddie T Chiang; Joe G N Garcia
Journal:  FASEB J       Date:  2005-10       Impact factor: 5.191

7.  Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.

Authors:  Yugesh Kharel; Mithun Raje; Ming Gao; Amanda M Gellett; Jose L Tomsig; Kevin R Lynch; Webster L Santos
Journal:  Biochem J       Date:  2012-10-01       Impact factor: 3.857

Review 8.  S1P control of endothelial integrity.

Authors:  Yuquan Xiong; Timothy Hla
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

9.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

10.  Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.

Authors:  Giovanni Marfia; Stefania Navone; Laura Guarnaccia; Rolando Campanella; Michele Mondoni; Marco Locatelli; Alessandra Barassi; Laura Fontana; Fabrizio Palumbo; Emanuele Garzia; Giuseppe Ciniglio Appiani; Davide Chiumello; Monica Miozzo; Stefano Centanni; Laura Riboni
Journal:  EMBO Mol Med       Date:  2020-12-09       Impact factor: 14.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.